Go Pro

Ovintiv (NYSE:OVV) Price Target Cut to $66.00 by Analysts at Citigroup

Ovintiv logo with Energy background
Image from MarketBeat Media, LLC.

Key Points

  • Citigroup cut Ovintiv’s price target from $70 to $66, but kept a Buy rating on the stock. The new target still implies about 14% upside from the current share price.
  • Other analysts also adjusted their views: some lowered targets, while others raised them, leaving Ovintiv with a Moderate Buy consensus and an average target price of about $65.63.
  • Ovintiv shares were up 2.5% on Friday to $57.87, and the company continues to attract heavy institutional ownership, with hedge funds and other investors holding more than 83% of the stock.
  • MarketBeat previews top five stocks to own in August.

Ovintiv (NYSE:OVV - Get Free Report) had its price target reduced by research analysts at Citigroup from $70.00 to $66.00 in a report issued on Friday,Benzinga reports. The firm currently has a "buy" rating on the stock. Citigroup's target price would indicate a potential upside of 14.05% from the stock's current price.

A number of other analysts have also weighed in on OVV. Morgan Stanley lowered their price objective on shares of Ovintiv from $68.00 to $65.00 and set an "equal weight" rating for the company in a research note on Monday, June 29th. National Bank Financial boosted their price target on shares of Ovintiv from $82.00 to $83.00 and gave the company an "outperform" rating in a report on Wednesday, July 8th. Stephens lowered their price target on shares of Ovintiv from $71.00 to $68.00 and set an "equal weight" rating for the company in a research report on Friday. Texas Capital upgraded shares of Ovintiv to a "strong-buy" rating in a research note on Thursday, June 25th. Finally, Barclays boosted their price objective on shares of Ovintiv from $68.00 to $75.00 and gave the stock an "overweight" rating in a research note on Tuesday, May 26th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and five have given a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $65.63.

Get Our Latest Report on Ovintiv

Ovintiv Trading Up 2.5%

OVV traded up $1.42 during trading on Friday, hitting $57.87. 3,066,931 shares of the stock were exchanged, compared to its average volume of 4,198,148. The firm has a 50 day simple moving average of $56.19 and a 200 day simple moving average of $52.33. The firm has a market cap of $16.26 billion, a price-to-earnings ratio of 18.67 and a beta of 0.53. Ovintiv has a 1 year low of $35.47 and a 1 year high of $63.46. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.56 and a current ratio of 0.56.

Hedge Funds Weigh In On Ovintiv

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Dimensional Fund Advisors LP lifted its stake in shares of Ovintiv by 17.8% during the fourth quarter. Dimensional Fund Advisors LP now owns 11,059,334 shares of the company's stock worth $433,418,000 after buying an additional 1,669,469 shares during the period. Charles Schwab Investment Management Inc. raised its stake in Ovintiv by 2.1% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 9,890,315 shares of the company's stock worth $387,601,000 after acquiring an additional 203,256 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its position in Ovintiv by 16.9% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 7,880,705 shares of the company's stock worth $467,874,000 after acquiring an additional 1,137,162 shares during the period. Millennium Management LLC lifted its position in Ovintiv by 116.3% during the 4th quarter. Millennium Management LLC now owns 5,692,806 shares of the company's stock worth $223,101,000 after acquiring an additional 3,060,691 shares during the period. Finally, Adage Capital Partners GP L.L.C. grew its stake in Ovintiv by 13.5% during the 4th quarter. Adage Capital Partners GP L.L.C. now owns 5,462,109 shares of the company's stock valued at $214,060,000 after purchasing an additional 650,000 shares during the last quarter. 83.81% of the stock is owned by hedge funds and other institutional investors.

Ovintiv News Summary

Here are the key news stories impacting Ovintiv this week:

  • Positive Sentiment: Zacks Research raised earnings estimates for multiple future periods, including Q3 2026, Q1 2027, Q2 2027, Q3 2027, Q4 2027, FY2027, Q1 2028, Q2 2028, and FY2028, which suggests analysts see somewhat stronger profitability ahead. MarketBeat OVV coverage
  • Neutral Sentiment: Recent coverage also noted that Ovintiv is expected to report earnings soon, and one Zacks preview said the company does not appear to have the best setup for an earnings beat, which may keep some investors cautious ahead of the release. Zacks article
  • Neutral Sentiment: Another article asked whether Ovintiv remains inexpensive after a strong five-year run, highlighting valuation discussion rather than a new company-specific catalyst. Yahoo Finance article
  • Negative Sentiment: Zacks Research trimmed its Q4 2026 EPS estimate slightly to $1.57 from $1.59 and kept a Hold rating, which adds a small note of caution near-term. MarketBeat OVV coverage

About Ovintiv

(Get Free Report)

Ovintiv Inc is a North American energy company focused on the exploration, development and production of oil, natural gas and natural gas liquids. Formerly known as Encana Corporation, the company rebranded as Ovintiv in January 2020 and established its headquarters in Denver, Colorado. Ovintiv's upstream portfolio spans multiple unconventional resource plays, reflecting a strategy centered on high-return projects and disciplined capital allocation.

The company's core business activities include the acquisition and development of acreage in major shale basins across the United States and Canada.

Recommended Stories

Analyst Recommendations for Ovintiv (NYSE:OVV)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Ovintiv Right Now?

Before you consider Ovintiv, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ovintiv wasn't on the list.

While Ovintiv currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines